- US pharma sees worsening China investment climate
- US Capitol Capsule: Of mice and men - and deadly viruses: tinkering with nature
- US Capitol Capsule: Time for optimism about Alzheimer's R&D?
- US Capitol Capsule: 'Cures' ain't law yet: Senate concurrence may be tricky
COMMENT Other Informa Comment
- 5 questions for Janssen India's boss on TB research and Sirturo
- INTERVIEW: Clinuvel's Philippe Wolgen on Scenesse and the patient factor